Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance

Authors

• Priya Bahri, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
• Geoffrey Bowring, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
• Brian D. Edwards, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
• Christopher Anton, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
• Jeffrey K. Aronson, University of Oxford Medical Sciences Division
• Angela Caro-Rojas, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
• Bruce P.J. Hugman
• Peter G. Mol, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
• Gianluca Trifirò, Università degli Studi di Verona
• Katarina Ilic, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
• Riadh Daghfous, Centre National de Pharmacovigilance
• Irene Fermont, Israel Society for Medication and Vaccine Safety (ERANIM)
• Giovanni Furlan, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
• Wolfgang Gaissmaier, Universität Konstanz
• Mohammad Ishaq Geer, University of Kashmir
• Kenneth Hartigan-Go, Ateneo School of GovernmentFollow
• François Houÿez, European Organisation for Rare Diseases (EURORDIS)
• Hansjörg Neth, Universität Konstanz
• Gediminas Norgela, Uppsala Monitoring Centre
• Yaowares Oppamayun, The Food and Drug Administration, Thailand Ministry of Public Health
• D. K.Theo Raynor, University of Leeds

Document Type

Article

Publication Date

6-1-2023

Recommended Citation

Bahri, P., Bowring, G., Edwards, B.D. et al. Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance. Drug Saf 46, 517–532 (2023). https://doi.org/10.1007/s40264-023-01285-5